findmyKOL
Clinical trialNCT02341209TerminatedPhase 2Interventional

Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma

SponsorRochester General HospitalEnrollment1Cutaneous T-cell LymphomaMycosis FungoidesSezary Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study looks at the efficacy of Doxycycline for the treatment of Cutaneous T-cell Lymphomas.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Rochester General Hospital

    Rochester, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Doxycycline →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
6 Feb 2018
Primary completion
6 Feb 2021
Completion
6 Feb 2021
Last update posted
27 Apr 2021
Registered enrollment
1
Registry id
NCT02341209
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.